Results 301 to 310 of about 710,185 (341)

Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy. [PDF]

Open Heart
Matama H, Asano R, Endo H, Takano R, Hayashi H, Fujisaki S, Tsujita K, Noguchi T, Ogo T.   +8 more
europepmc   +1 more source

OP0333 INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE

H.J. Bjørkekjær, C. Bruni, K. Broch, Cathrine Brunborg, P. Carreira Delgado, Paolo Airò, Carmen Pilar Simeón‐Aznar, M.E. Truchetet, Alessandro Giollo, A. Balbir-Gurman, M. Martin, Christopher P. Denton, Andrea Gabrielli, F. Galdo, Madelon C Vonk, H. Fretheim, Helle Bitter, Ø. Midtvedt, A.K. Andreassen, S. Høie, Y. Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, M. Matucci-Cerinic, I. Castellví, Elise Siegert, É. Hachulla, Ø. Molberg, O. Distler, A.M. Hoffmann-Vold   +29 more
openalex   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors? [PDF]

Cells
Wang L, Fischmeister R, Manoury B.
europepmc   +1 more source

Washington University Medical Alumni Quarterly, July 1951 [PDF]

, 1951

core   +1 more source

Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021. [PDF]

Medicine (Baltimore)
Lu Y, Zhang J, Lan T, He J.
europepmc   +1 more source

Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Hjalmarsson C, Thakur T, Rådegran G, Björklund E, Wåhlander H, Nisell M, Papageorgiou JM, Söderberg S, Lautsch D, Kjellström B.   +9 more
europepmc   +1 more source

RENAISSANCE OF ARTERIAL HYPERTENSION MONOTHERAPY – THE POSITION OF THIAZIDE DIURETICS

, 2012
T. V. Adasheva, Zadionchenko Vs, Z. O. Grineva, А. М. Щикота   +3 more
openalex   +1 more source

Corrigendum to ''Sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation'' [JHLT Open (2025) 100213]. [PDF]

JHLT Open
Rosenheck JP, Goyal K, Fallah T, Burcham P, Choi K, Henn M, Homsy E, Visovatti S, Franco V.   +8 more
europepmc   +1 more source

Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension. [PDF]

JACC Basic Transl Sci
Moutsoglou D, Blake M, Belhasan DC, Peichel G, Vang BM, Weir EK, Lopez S, Prins KW, Kabage AJ, Prisco SZ, Kremer BP, Khoruts A, Thenappan T.   +12 more
europepmc   +1 more source